Subgroups according to BASDAI/ASDAS category (baseline)

Baseline values and 3-month response in subgroups according to CRP

A and B, Percentages of patients in the golimumab (GLM) and placebo

Frontiers The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis

Frontiers The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis

Frontiers The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis

Moxibustion for ankylosing spondylitis: A systematic review and meta-analysis - ScienceDirect

Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis - The Lancet Rheumatology

Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis

Mean change in modified total Sharp score for C-reactive protein

Extended Report Semantic Scholar